Philips Medical Systems (Cleveland), Inc. v. Buan

District Court, N.D. Illinois·Decided November 22, 2021·No. 1:19-cv-02648·Unknown

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

PHILIPS MEDICAL SYSTEMS ) (CLEVELAND), INC., and PHILIPS ) MEDICAL SYSTEMS DMC, GmbH, ) ) Plaintiffs, ) ) v. ) No. 1:19 CV 02648 ) Hon. Marvin E. Aspen JOSE BUAN, GL LEADING ) TECHNOLOGIES, INC., KUNSHAN ) YIYUAN MEDICAL TECHNOLOGY CO., ) LTD., KUNSHAN GUOLI ELECTRONIC ) TECHNOLOGY CO., LTD., and ) SHERMAN JEN, ) ) Defendants. )

MEMORANDUM OPINION AND ORDER

MARVIN E. ASPEN, District Judge: In this case involving allegations of trade secret misappropriation, Defendants Jose Buan, GL Leading Technologies, Inc., Kunshan Yiyuan Medical Technology, Co., Ltd., Kunshan GuoLi Electronic Technology Co., Ltd., and Sherman Jen have moved to bifurcate proceedings under Federal Rule of Civil Procedure 42(b). (Defendants’ Motion for Separate Trials of Liability and Damages (“Motion”) (Dkt. Nos. 317, 318).)1 Specifically, Defendants seek to bifurcate the issue of liability from the issue of damages and to stay all discovery regarding damages. (Id. at 1.) For the reasons set forth below, we deny the motion.

1 For ECF filings, we cite the page number(s) set forth in the document’s ECF header unless citing to a particular paragraph or other page designation is more appropriate. BACKGROUND Plaintiffs Philips Medical Systems (Cleveland), Inc. and Philips Medical Systems DMC, GmbH initiated this lawsuit in April 2019 by suing GL Leading Technologies, Inc. and Jose Buan for trade secret misappropriation, unjust enrichment, and breach of contract. (Complaint

(Dkt. No. 1).) After conducting some discovery, Plaintiffs amended the Complaint to add Kunshan Yiyuan Medical Technology, Co., Ltd. and Kunshan GuoLi Electronic Technology Co., Ltd. (the “Overseas Defendants”) as defendants on November 29, 2019. (First Amended Complaint (Dkt. No. 46).) Plaintiffs later added Sherman Jen as a defendant on March 30, 2020. (Second Amended Complaint (Dkt. No. 92).) Over the past two years, the parties have briefed numerous motions, including multiple motions to compel interrogatory responses (see, e.g., Dkt. Nos. 41, 69, 157, 179); Overseas Defendants’ motions to dismiss pursuant to Federal Rules of Civil Procedure 12(b)(2), (4), and (5) (see Dkt. Nos. 158, 161); Overseas Defendants’ motion to exclude exhibits attached to Plaintiffs’ opposition to Overseas Defendants’ Rule 12(b)(2), (4), and (5) motions (see Dkt. No.

209); Overseas Defendants’ motion to reconsider the Magistrate Judge’s order on the motion to exclude exhibits (see Dkt. No. 259); Overseas Defendants’ motion to dismiss pursuant to the doctrine of forum non conveniens or, in the alternative, to stay the case under the Colorado River abstention doctrine (Dkt. No. 285); and the instant motion to bifurcate (Dkt. Nos. 317, 318). During this time, the parties have exchanged some discovery (see, e.g., Dkt. No. 273 (discussing discovery that had occurred as of February 25, 2021)), but significant issues remain unresolved (see, e.g., Dkt. No. 323 (“Parties report that there are significant issues with written discovery” as of October 29, 2021)). LEGAL STANDARD Federal Rule of Civil Procedure 42(b) provides that “[f]or convenience, to avoid prejudice, or to expedite and economize, the court may order a separate trial of one or more separate issues, claims, crossclaims, counterclaims, or third-party claims.” Fed. R. Civ. P. 42(b).

Motions to bifurcate are decided on a case-by-case basis and are left to the court’s discretion. See Est. of Loury by Hudson v. City of Chicago, Case No. 16-cv-4452, 2020 WL 1491141, at *1 (N.D. Ill. Mar. 27, 2020); Edge Capture L.L.C. v. Barclays Bank PLC, Civil Action No. 09 CV 1521, 2011 WL 13272663, at *1 (N.D. Ill. Apr. 21, 2011). A district court may bifurcate a trial so long as bifurcation: (1) promotes judicial economy or is done to avoid prejudice to a party; (2) does not unfairly prejudice the non-moving party; and (3) does not violate the Seventh Amendment. Chlopek v. Fed. Ins. Co., 499 F.3d 692, 700 (7th Cir. 2007); Houseman v. U.S. Aviation Underwriters, 171 F.3d 1117, 1121 (7th Cir. 1999). The party seeking bifurcation bears the burden of proving that “judicial economy would be served and the balance of potential prejudice weighs in favor of bifurcation.” Trading Techs. Int’l, Inc. v. eSpeed, Inc., 431 F. Supp.

2d 834, 837 (N.D. Ill. 2006) (internal citation omitted); see also BASF Catalysts LLC v. Aristo, Inc., Cause No. 2:07-cv-222, 2009 WL 523123, at *2 (N.D. Ind. Mar. 2, 2009). Bifurcation “is the exception, not the rule.” Edge Capture, 2011 WL 13272663, at *1 (internal citation and quotation marks omitted); BASF Catalysts, 2009 WL 523123, at *2; Real v. Bunn-O-Matic Corp., 195 F.R.D. 618, 620 (N.D. Ill. 2000). ANALYSIS I. Bifurcation Defendants argue that bifurcation would benefit the Court, the parties, and any potential jury. (Motion at 4–10.) According to Defendants, the claims in this case are so numerous and complex that if we do not bifurcate the case, there is a risk that a jury would be confused. (Id. at 7–9.) Additionally, Defendants contend that bifurcation would promote discovery-related economies. (Id. at 6–7.) Specifically, the parties could begin with liability-related discovery, and after liability is decided, conduct damages-related discovery limited to the claims where liability was found. (Id.) As a result of this phased approach, Defendants might not have to

produce or translate as many documents, and there would be less of a risk of inadvertent disclosure of sensitive financial information. (Id.) Plaintiffs would not have to “undertake the burden and expense of . . . potentially unneeded damages discovery” either. (Id. at 9.) In response, Plaintiffs argue that courts in this district have tried patent infringement cases of equal or greater complexity without bifurcation, and we should be able to do so here. (Plaintiffs’ Opposition to Defendants’ Motion for Separate Trial of Liability and Damages (“Opp’n”) (Dkt. Nos. 327, 328) at 6–7.) They disagree with Defendants about the economies of bifurcation, arguing that bifurcation will likely cause additional delays and expense. (Id. at 9– 13.) As for Defendants’ concerns regarding translation and the disclosure of confidential information, Plaintiffs argue that translation services are readily available, and we should not be

concerned about the disclosure of confidential information because Defendants are represented by the same counsel and routinely share information with one another as part of their operations. (Id. at 14–15.) We agree that the issues in this case are not so complex as to require bifurcation. As Plaintiffs note, juries in this district have considered cases of equal or greater complexity. (See Opp’n at 6–7.) For example, in Motorola Solutions, Inc. v. Hytera Communications Corp., 495 F. Supp. 3d 687 (N.D. Ill. 2020), a jury sat through a three-and-a-half-month-long trial concerning the alleged misappropriation of trade secrets by former Motorola employees who began working for Hytera. The jury considered “complex technological, factual, and legal issues,” and awarded Motorola damages of more than $760 million. Id. at 695. To the extent that juror confusion nonetheless remains a concern, we have other means of dealing with it, such as using “cautionary warnings, limiting instructions, special verdict forms, and other jury instructions.” See BASF Catalysts, 2009 WL 523123, at *2.

Free access — add to your briefcase to read the full text and ask questions with AI

Philips Medical Systems (Cleveland), Inc. v. Buan, (N.D. Ill. 2021).

Philips Medical Systems (Cleveland), Inc. v. Buan (Philips Medical Systems (Cleveland), Inc. v. Buan) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Chlopek v. Federal Insurance
499 F.3d 692 (Seventh Circuit, 2007)
Trading Technologies International, Inc. v. Espeed, Inc.
431 F. Supp. 2d 834 (N.D. Illinois, 2006)
Real v. Bunn-O-Matic Corp.
195 F.R.D. 618 (N.D. Illinois, 2000)